Intellectual Property India Publishes Patent Application for 'Nucleic Acids Encoding Soluble Pd-1 And Il-12 And Uses Thereof' Filed by Kalivir Immunotherapeutics, Inc.

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517037272 A) filed by Kalivir Immunotherapeutics, Inc., Pittsburgh, on April 17, for 'nucleic acids encoding soluble pd-1 and il-12 and uses thereof.'

Inventor(s) include Thorne, Stephen Howard; and Zhang, Mingrui.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides for nucleic acids encoding for a soluble PD-1 variant and IL-12. Further provided herein are nucleic acids encoding for a chemokine receptor. Additionally described herein are oncolytic viruses comprising the nucleic acids described herein. Oncolytic viru...